Rebecca Miksad, MD, MPH
|Assistant Professor of Medicine, Harvard Medical School|
|Attending Physician in Gastrointestinal Malignancies, Beth Israel Deaconess Medical Center|
|Location:||Institute for Technology Assessment
Massachusetts General Hospital
101 Merrimac St., 10th FL
Boston, MA 02114
Rebecca is engaged in oncology health services and outcomes research as a Senior Scientist with the Institute for Technology Assessment, an attending oncologist specializing in gastrointestinal malignancies at Beth Israel Deaconess Medical Center (BIDMC) and an Instructor in Medicine at Harvard Medical School. Her current and past research support includes the PCORT fellowship, the Young Investigator’s Award from the American Society of Clinical Oncology, the Timely Special Opportunity Award from the Dana-Farber Cancer Institute, the NIH Loan Repayment Program and the Clinical Research Feasibility Fund Award from BIDMC. Recent awards include the Lee Lusted Prize for outstanding research from the Society for Medical Decision Making and the Clinical Research Award from the Eastern Cooperative Oncology Group.
In the Spring of 2011, Rebecca recorded a podcast entitled "Pathologic Complete Response and Toxicity Results from the STAR-01 Trial Evaluating the Addition of Oxaliplatin to Neodjuvant Chemoradiation for Locally Advanced Rectal Cancer"